Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GPAT-IN-1
Cat. No.:
OB0425LY-183
Appearance:
Solid
Purity:
97.12%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
GPAT-IN-1 is a compound that specifically inhibits Glycerol-3-phosphate acyltransferase (GPAT), which plays an important role in lipid metabolism.
Synonyms:
1204347-51-2; GPAT-IN-1; GPAT IN 1;GPAT-IN1
CAS No.:
1204347-51-2
Compound CID:
44608763
Formula:
C21H26ClNO4S
Formula Weight:
423.95
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
GPAT-IN-1 can be used to study lipid metabolic processes, obesity and related metabolic diseases.
